Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 04, 2024 07:30 ET | Source: Jnana Therapeutics, Inc.

Jnana Therapeutics Presents New Positive Data from Phase 1/2 Study of JNT-517 in Individuals with Phenylketonuria – Results Support Planned Pivotal Study in Early 2025

Jnana Therapeutics presents new positive data at SSIEM 2024 from Phase 1/2 study of JNT-517 in individuals with phenylketonuria (PKU).
August 01, 2024 00:01 ET | Source: Jnana Therapeutics, Inc.

Otsuka Pharmaceutical to Acquire Jnana Therapeutics Inc.

Otsuka Pharmaceutical to acquire Jnana Therapeutics Inc.
May 08, 2024 08:00 ET | Source: Jnana Therapeutics, Inc.

Jnana Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference

Jnana CEO Joanne Kotz will present a corporate overview at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024 at 2:05 p.m. ET.
December 06, 2023 08:00 ET | Source: Jnana Therapeutics, Inc.

Jnana Therapeutics to Present at the RBC Capital Markets Healthcare Private Company Virtual Conference

Jnana Therapeutics CEO Joanne Kotz will participate in a fireside chat on Dec. 13 at the RBC Capital Markets Healthcare Private Company Conference.
October 05, 2023 08:00 ET | Source: Jnana Therapeutics, Inc.

Jnana Therapeutics to Participate in Upcoming Investor Conferences

BOSTON, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets,...
September 06, 2023 08:00 ET | Source: Jnana Therapeutics, Inc.

Jnana Therapeutics to Participate in Upcoming Investor Conferences

BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets,...
May 24, 2023 07:00 ET | Source: Jnana Therapeutics, Inc.

Jnana Therapeutics Announces Milestone Achieved Under First Collaboration with Roche

Achievement of research milestone for immune program triggers milestone payment BOSTON, May 24, 2023 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a clinical-stage biotechnology company leveraging its...